ICH Plans Drug Development Guideline to Boost Trial Design
May 31, 2022
A planned International Council for Harmonization (ICH) guideline on model-informed drug development (MIDD) will help optimize clinical trial designs, according to ICH, which estimates development of the guideline will be complete in three to four years.